4344-73-4

Basic information

• Product Name: 1,2,4,5,6,7-Hexahydro-indazol-3-one
• Synonyms: 1,2,4,5,6,7-Hexahydro-indazol-3-one;4,5,6,7-tetrahydro-1H-indazol-3(2H)-one
• CAS NO: 4344-73-4
• Molecular Formula: C₇H₁₀N₂O
• Molecular Weight: 138.1671
• EINECS: -0
• Mol File: 4344-73-4.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,2,4,5,6,7-Hexahydro-indazol-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,4,5,6,7-Hexahydro-indazol-3-one(4344-73-4)
• EPA Substance Registry System: 1,2,4,5,6,7-Hexahydro-indazol-3-one(4344-73-4)

Safety Data

• Hazardous Substances Data: 4344-73-4(Hazardous Substances Data)

Usage

General Description

1,2,4,5,6,7-Hexahydro-indazol-3-one is a chemical compound with the molecular formula C9H11NO. It is a cyclic organic compound that contains a nitrogen atom within the ring structure. 1,2,4,5,6,7-Hexahydro-indazol-3-one has been studied for its potential pharmaceutical and medicinal applications, including its role as a potential building block for the synthesis of biologically active molecules. It is also used in organic synthesis as a building block for the construction of diverse chemical structures. Additionally, 1,2,4,5,6,7-Hexahydro-indazol-3-one has been investigated for its potential biological activities, such as its antimicrobial and anticonvulsant properties, making it a subject of interest for further research and development in the fields of medicinal chemistry and pharmaceutical science.

Upstream product

• 13054-47-2 4,5,6,7-tetrahydro-benzo[c]isoxazol-3-ylamine 
• 16064-21-4 2-sulfanylidene-1,2,3,4,5, 6,7,8-octahydroquinazolin-4-one 
• 34170-21-3 2-methylsulfanyl-5.6.7.8-tetrahydro-3H-quinazolin-4-one 
• 41302-34-5 2-(methoxycarbonyl)cyclohexanone 
• 1655-07-8 ethyl 2-oxocyclohexane carboxylate 
• 107154-16-5 2-methylsulfanyl-3-phenyl-5,6,7,8-tetrahydro-3H-quinazolin-4-one 
• 7803-57-8 hydrazine hydrate 
• 7364-25-2 1H-indazol-3-ol 

Downstream Products

• 19462-59-0 3,4-tetramethylene-4-chloro-2-pyrazolin-5-one 
• 7364-25-2 3-indazolinone 
• 52046-92-1 1-benzyl-3-<3-(dimethylamino)propoxy>-4,5,6,7-tetrahydro-1H-indazole 
• 1022144-67-7 C₂₅H₂₅N₅O₅ 

Relevant articles and documents

COMPOUNDS AS GLP-1R AGONISTS

The present application provides compounds that may be used as a glucagon-like peptide-1 receptors (GLP-1R) agonist, or stereoisomers, tautomers, or pharmaceutically acceptable salts of any of the foregoing. Also provided are pharmaceutical compositions containing such compounds, or stereoisomers, tautomers, or pharmaceutically acceptable salts of any of the foregoing. Methods of prepare these compounds and compositions and method of using them to treat or present a disease or a condition mediated by GLP-1R.

NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

The present invention encompasses compounds of Formula (I) as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also

Synthesis of 1-Substituted 3-(Dialkylaminoalkoxy)-4,5,6,7-tetrahydro-1H-indazoles

4,5,6,7-Tetrahydro-3-indazolone was prepared by catalytic hydrogenation of 3-indazolone, and its reaction with dialkylaminoalkyl chloride was studied.In addition, a number of 1-substituted 3-(dialkylaminoalkoxy)-4,5,6,7-tetrahydro-1H-indazoles were prepar